Parse Biosciences Garners $41.5M Series B

Feb 15, 2022•over 3 years ago

Amount Raised

$41.5 Million

Round Type

series b

Description

Parse Biosciences, a provider of scalable single-cell sequencing solutions, has secured $41.5 million in Series B funding.

Company Information

Company

Parse Biosciences

About

Parse Biosciences is providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease. Learn more about how you can use the most scalable single cell platform on the market without the need for custom instrumentation.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Parse Biosciences Garners $41.5M Series B

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information